• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

是膀胱癌预后的一个新标志物:基于实验研究、机器学习和单细胞测序的证据。

is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing.

机构信息

Department of Urology, Jinzhou Medical University, The First Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.

Department of Clinical Lab, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.

出版信息

Front Immunol. 2024 Aug 21;15:1419126. doi: 10.3389/fimmu.2024.1419126. eCollection 2024.

DOI:10.3389/fimmu.2024.1419126
PMID:39234248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11371609/
Abstract

BACKGROUND

Bladder cancer, a highly fatal disease, poses a significant threat to patients. Positioned at 19q13.2-13.3, LIG1, one of the four DNA ligases in mammalian cells, is frequently deleted in tumour cells of diverse origins. Despite this, the precise involvement of LIG1 in BLCA remains elusive. This pioneering investigation delves into the uncharted territory of LIG1's impact on BLCA. Our primary objective is to elucidate the intricate interplay between LIG1 and BLCA, alongside exploring its correlation with various clinicopathological factors.

METHODS

We retrieved gene expression data of para-carcinoma tissues and bladder cancer (BLCA) from the GEO repository. Single-cell sequencing data were processed using the "Seurat" package. Differential expression analysis was then performed with the "Limma" package. The construction of scale-free gene co-expression networks was achieved using the "WGCNA" package. Subsequently, a Venn diagram was utilized to extract genes from the positively correlated modules identified by WGCNA and intersect them with differentially expressed genes (DEGs), isolating the overlapping genes. The "STRINGdb" package was employed to establish the protein-protein interaction (PPI) network.Hub genes were identified through the PPI network using the Betweenness Centrality (BC) algorithm. We conducted KEGG and GO enrichment analyses to uncover the regulatory mechanisms and biological functions associated with the hub genes. A machine-learning diagnostic model was established using the R package "mlr3verse." Mutation profiles between the LIG1^high and LIG1^low groups were visualized using the BEST website. Survival analyses within the LIG1^high and LIG1^low groups were performed using the BEST website and the GENT2 website. Finally, a series of functional experiments were executed to validate the functional role of LIG1 in BLCA.

RESULTS

Our investigation revealed an upregulation of LIG1 in BLCA specimens, with heightened LIG1 levels correlating with unfavorable overall survival outcomes. Functional enrichment analysis of hub genes, as evidenced by GO and KEGG enrichment analyses, highlighted LIG1's involvement in critical function such as the DNA replication, cellular senescence, cell cycle and the p53 signalling pathway. Notably, the mutational landscape of BLCA varied significantly between LIG1 and LIG1 groups.Immune infiltrating analyses suggested a pivotal role for LIG1 in immune cell recruitment and immune regulation within the BLCA microenvironment, thereby impacting prognosis. Subsequent experimental validations further underscored the significance of LIG1 in BLCA pathogenesis, consolidating its functional relevance in BLCA samples.

CONCLUSIONS

Our research demonstrates that LIG1 plays a crucial role in promoting bladder cancer malignant progression by heightening proliferation, invasion, EMT, and other key functions, thereby serving as a potential risk biomarker.

摘要

背景

膀胱癌是一种致命性很高的疾病,对患者构成重大威胁。位于 19q13.2-13.3 的 LIG1 是哺乳动物细胞中的四种 DNA 连接酶之一,在不同来源的肿瘤细胞中经常缺失。尽管如此,LIG1 在膀胱癌中的确切作用仍不清楚。这项开创性的研究深入探讨了 LIG1 对膀胱癌的影响。我们的主要目标是阐明 LIG1 与膀胱癌之间错综复杂的相互作用,并探讨其与各种临床病理因素的相关性。

方法

我们从 GEO 数据库中检索了癌旁组织和膀胱癌 (BLCA) 的基因表达数据。使用“Seurat”软件包处理单细胞测序数据。使用“Limma”软件包进行差异表达分析。使用“WGCNA”软件包构建无标度基因共表达网络。随后,使用 Venn 图从 WGCNA 鉴定的正相关模块中提取基因,并与差异表达基因 (DEGs) 进行交集,分离重叠基因。使用“STRINGdb”软件包建立蛋白质-蛋白质相互作用 (PPI) 网络。使用节点之间的中间中心度 (BC) 算法从 PPI 网络中识别枢纽基因。我们进行了 KEGG 和 GO 富集分析,以揭示与枢纽基因相关的调控机制和生物学功能。使用 R 包“mlr3verse”建立机器学习诊断模型。使用 BEST 网站可视化 LIG1^high 和 LIG1^low 组之间的突变谱。使用 BEST 网站和 GENT2 网站在 LIG1^high 和 LIG1^low 组内进行生存分析。最后,进行了一系列功能实验来验证 LIG1 在 BLCA 中的功能作用。

结果

我们的研究表明,LIG1 在 BLCA 标本中上调,LIG1 水平升高与总生存期不良相关。通过 GO 和 KEGG 富集分析,对枢纽基因进行功能富集分析,突出了 LIG1 在 DNA 复制、细胞衰老、细胞周期和 p53 信号通路等关键功能中的作用。值得注意的是,LIG1 和 LIG1 组之间的膀胱癌突变图谱差异显著。免疫浸润分析表明,LIG1 在膀胱癌微环境中的免疫细胞募集和免疫调节中发挥关键作用,从而影响预后。随后的实验验证进一步强调了 LIG1 在 BLCA 发病机制中的重要性,巩固了其在 BLCA 样本中的功能相关性。

结论

我们的研究表明,LIG1 通过增强增殖、侵袭、EMT 等关键功能,在促进膀胱癌恶性进展中发挥关键作用,因此可作为潜在的风险生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/62e9d52503e4/fimmu-15-1419126-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/d755e2abb70a/fimmu-15-1419126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/f08b213fd23f/fimmu-15-1419126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/8982a4e98432/fimmu-15-1419126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/35b4aec9bff7/fimmu-15-1419126-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/585bc62f911d/fimmu-15-1419126-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/339b9d8f8498/fimmu-15-1419126-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/0c5664b415cf/fimmu-15-1419126-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/62e9d52503e4/fimmu-15-1419126-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/d755e2abb70a/fimmu-15-1419126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/f08b213fd23f/fimmu-15-1419126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/8982a4e98432/fimmu-15-1419126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/35b4aec9bff7/fimmu-15-1419126-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/585bc62f911d/fimmu-15-1419126-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/339b9d8f8498/fimmu-15-1419126-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/0c5664b415cf/fimmu-15-1419126-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbf5/11371609/62e9d52503e4/fimmu-15-1419126-g008.jpg

相似文献

1
is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing.是膀胱癌预后的一个新标志物:基于实验研究、机器学习和单细胞测序的证据。
Front Immunol. 2024 Aug 21;15:1419126. doi: 10.3389/fimmu.2024.1419126. eCollection 2024.
2
Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.鉴定一个与肿瘤微环境相关的七基因标志物,用于预测膀胱癌的预后。
BMC Cancer. 2021 Jun 10;21(1):692. doi: 10.1186/s12885-021-08447-7.
3
Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.COL10A1 在尿路上皮膀胱癌中的预后价值及其与肿瘤浸润免疫细胞的相关性:基于生物信息学和临床分析验证的综合研究。
Front Immunol. 2023 Mar 17;14:955949. doi: 10.3389/fimmu.2023.955949. eCollection 2023.
4
TCGA Database-Based Screening of Tumor Microenvironment Immunomodulators Related to Bladder Cancer Prognosis.基于TCGA数据库筛选与膀胱癌预后相关的肿瘤微环境免疫调节剂
Ann Clin Lab Sci. 2024 May;54(3):299-312.
5
Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancer.整合单细胞 RNA 测序以识别基于成纤维细胞的分子亚型,用于预测膀胱癌的预后和治疗反应。
Aging (Albany NY). 2024 Jul 18;16(14):11385-11408. doi: 10.18632/aging.206021.
6
Exploring the Shared Gene Signatures and Molecular Mechanisms between Bladder Urothelial Carcinoma and Metabolic Syndrome.探讨膀胱癌和代谢综合征之间的共享基因特征和分子机制。
Arch Esp Urol. 2023 Oct;76(8):605-621. doi: 10.56434/j.arch.esp.urol.20237608.75.
7
Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.综合分析 scRNA-Seq 和 bulk RNA-Seq 揭示膀胱癌肿瘤免疫微环境的动态变化,并建立一个预后模型。
J Transl Med. 2023 Mar 27;21(1):223. doi: 10.1186/s12967-023-04056-z.
8
Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis.基于综合生物信息学分析鉴定膀胱癌进展和预后相关的枢纽基因。
Arch Esp Urol. 2022 Nov;75(9):779-790. doi: 10.56434/j.arch.esp.urol.20227509.114.
9
Identifying possible hub genes and biological mechanisms shared between bladder cancer and inflammatory bowel disease using machine learning and integrated bioinformatics.利用机器学习和综合生物信息学方法,识别膀胱癌和炎症性肠病之间可能存在的共享枢纽基因和生物学机制。
J Cancer Res Clin Oncol. 2023 Dec;149(18):16885-16904. doi: 10.1007/s00432-023-05266-0. Epub 2023 Sep 23.
10
Integrated transcriptome analysis of CSE1L regarding poor prognosis and immune infiltration in bladder urothelial carcinoma and experimental verification.CSE1L 整体转录组分析与膀胱癌不良预后和免疫浸润的关系及实验验证。
Front Immunol. 2024 Oct 4;15:1449251. doi: 10.3389/fimmu.2024.1449251. eCollection 2024.

引用本文的文献

1
Cellular senescence in cancer: from mechanism paradoxes to precision therapeutics.癌症中的细胞衰老:从机制悖论到精准治疗
Mol Cancer. 2025 Aug 8;24(1):213. doi: 10.1186/s12943-025-02419-2.
2
Identification and single-cell analysis of prognostic genes related to mitochondrial and neutrophil extracellular traps in bladder cancer.膀胱癌中线粒体和中性粒细胞胞外诱捕网相关预后基因的鉴定及单细胞分析
Sci Rep. 2025 Jul 4;15(1):23982. doi: 10.1038/s41598-025-10413-3.
3
Intervention of machine learning in bladder cancer research using multi-omics datasets: systematic review on biomarker identification.

本文引用的文献

1
A gene signature of cancer-associated fibroblasts predicts prognosis and treatment response in bladder cancer.癌症相关成纤维细胞的基因特征可预测膀胱癌的预后和治疗反应。
Clin Transl Oncol. 2024 Feb;26(2):477-495. doi: 10.1007/s12094-023-03270-x. Epub 2023 Aug 18.
2
Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.基于机器学习生存框架的膀胱癌中二硫键相关亚型的串扰、预后特征模型的建立和免疫浸润特征分析。
Front Endocrinol (Lausanne). 2023 Apr 19;14:1180404. doi: 10.3389/fendo.2023.1180404. eCollection 2023.
3
利用多组学数据集的机器学习在膀胱癌研究中的干预:生物标志物识别的系统评价
Discov Oncol. 2025 Jun 5;16(1):1010. doi: 10.1007/s12672-025-02734-6.
On the importance of interpretable machine learning predictions to inform clinical decision making in oncology.
论可解释机器学习预测对肿瘤学临床决策的重要性。
Front Oncol. 2023 Feb 28;13:1129380. doi: 10.3389/fonc.2023.1129380. eCollection 2023.
4
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice.膀胱癌流行病学的全球趋势:公共卫生和临床实践面临的挑战。
Nat Rev Clin Oncol. 2023 May;20(5):287-304. doi: 10.1038/s41571-023-00744-3. Epub 2023 Mar 13.
5
Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?膀胱癌中的肿瘤微环境与上皮-间质转化:细胞因子参与其中?
Front Mol Biosci. 2023 Jan 9;9:1070383. doi: 10.3389/fmolb.2022.1070383. eCollection 2022.
6
An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer.用于鉴定膀胱癌诊断、预后和预测关键生物标志物的综合生物信息学分析
Cancers (Basel). 2022 Jul 10;14(14):3358. doi: 10.3390/cancers14143358.
7
Identification of Potential Biomarkers for Progression and Prognosis of Bladder Cancer by Comprehensive Bioinformatics Analysis.通过综合生物信息学分析鉴定膀胱癌进展和预后的潜在生物标志物
J Oncol. 2022 Apr 19;2022:1802706. doi: 10.1155/2022/1802706. eCollection 2022.
8
Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking.单细胞分析人类支气管上皮细胞中的体细胞突变与衰老和吸烟的关系。
Nat Genet. 2022 Apr;54(4):492-498. doi: 10.1038/s41588-022-01035-w. Epub 2022 Apr 11.
9
Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day.晚期膀胱癌中的免疫检查点抑制剂:把握当下。
Biomedicines. 2022 Feb 9;10(2):411. doi: 10.3390/biomedicines10020411.
10
Checkpoint Inhibition in Bladder Cancer: Clinical Expectations, Current Evidence, and Proposal of Future Strategies Based on a Tumor-Specific Immunobiological Approach.膀胱癌中的检查点抑制:基于肿瘤特异性免疫生物学方法的临床预期、当前证据及未来策略建议
Cancers (Basel). 2021 Nov 29;13(23):6016. doi: 10.3390/cancers13236016.